Evofosfamide, CAS 918633-87-1 Sole GMP Manufacturer
Evofosfamide, CAS 918633-87-1 stable novel crystalline or amorphous form both we have, Evofosfamide, CAS 918633-87-1no any IP problem. Evofosfamide, CAS 918633-87-1 DMF filling, free sample of Evofosfamide, CAS 918633-87-1.
EOS Med Chem have already carried out Evofosfamide, CAS 918633-87-1 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Evofosfamide, CAS 918633-87-1 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Evofosfamide, CAS 918633-87-1 Intermeidates list, most from GMP plant:
| Evofosfamide, CAS 918633-87-1 Intermediate, 794492-64-1, stock 2.2kg, assay 99%, White powder. |
| Evofosfamide, CAS 918633-87-1 Intermediate, 1698898-24-6, stock 9.7kg, assay 98.3%, White powder. |
| Evofosfamide, CAS 918633-87-1 Intermediate, 177760-04-2, stock 4.1kg, assay 98%, White powder. |
| Evofosfamide, CAS 918633-87-1 Intermediate, 39070-13-8, stock 6.7kg, assay 98.5%, White powder. |
| Evofosfamide, CAS 918633-87-1 Intermediate, 50700-55-5, stock 7.8kg, assay 98.8%, White powder. |
| Evofosfamide, Intermediate 141025-16-3, stock 9.9kg, assay 98.4%, White powder. |
| Evofosfamide, Intermediate 39070-14-9, stock 3.8kg, assay 98.5%, White powder. |
| Evofosfamide, Intermediate 918633-87-1, stock 4.2kg, assay 98.3%, White powder. |
Evofosfamide, CAS 918633-87-1 HNMR, MASS, COA, MSDS we have.
Evofosfamide, CAS 918633-87-1, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
